Pacific Biosciences of California, Inc.
PACB
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparatioā¦ read more
Healthcare
Medical Devices
15 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.35
Price+9.76%
$0.12
1Y
Price
Market Cap
$419.312m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-15.5%
EBITDA Margin-22.3%
Net Profit Margin-128.4%
Free Cash Flow Margin-15.5%
EBITDA Margin-22.3%
Net Profit Margin-128.4%
Free Cash Flow MarginRevenue
$160.030m
+0.0%
1y CAGR-6.4%
3y CAGR+9.3%
5y CAGREarnings
-$128.576m
+76.5%
1y CAGR-0.3%
3y CAGR+0.4%
5y CAGREPS
-$0.43
+76.4%
1y CAGR+6.0%
3y CAGR+7.9%
5y CAGRBook Value
$2.366m
$782.365m
Assets$779.999m
Liabilities$703.388m
DebtDebt to Assets
89.9%
-6.6x
Debt to EBITDAFree Cash Flow
-$116.212m
-2.0%
1y CAGR+22.4%
3y CAGR+17.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company